Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

N-acetylcysteine: multiple clinical applications.

Millea PJ.

Am Fam Physician. 2009 Aug 1;80(3):265-9. Review.

2.

Clinical applications of N-acetylcysteine.

Kelly GS.

Altern Med Rev. 1998 Apr;3(2):114-27. Review.

3.

[Acetylcysteine in chronic obstructive pulmonary disease. Secretolytic, antioxidant or placebo?].

Randerath W, Galetke W.

Med Monatsschr Pharm. 2003 Nov;26(11):375-8. Review. German. No abstract available.

PMID:
14652922
4.

[Mucolytics in acute and chronic respiratory tract disorders. II. Uses for treatment and antioxidant properties].

Kupczyk M, Kuna P.

Pol Merkur Lekarski. 2002 Mar;12(69):248-52. Review. Polish.

PMID:
12053601
5.

[N-Acetylcysteine: new possibilities to use an old substance].

Ahola T, Lapatto R.

Duodecim. 1999;115(4):375-9. Review. Finnish. No abstract available.

PMID:
11830885
6.

Acute acetaminophen overdose in adolescents and adults.

Hamm J.

Crit Care Nurse. 2000 Jun;20(3):69-74. Review. No abstract available.

PMID:
11876216
7.

[Value of N-acetylcysteine to prevent nephrotoxicity from iodinated contrast agents].

Deray G.

J Radiol. 2004 Jun;85(6 Pt 1):725-7. Review. French.

8.

Comparison of oral and i.v. acetylcysteine in the treatment of acetaminophen poisoning.

Kanter MZ.

Am J Health Syst Pharm. 2006 Oct 1;63(19):1821-7. Review.

PMID:
16990628
9.

N-acetylcysteine administration in the critically ill.

Walsh TS, Lee A.

Intensive Care Med. 1999 May;25(5):432-4. Review. No abstract available.

PMID:
10401934
10.

A case of haemodialysis-associated pseudoporphyria successfully treated with oral N-acetylcysteine.

Cooke NS, McKenna K.

Clin Exp Dermatol. 2007 Jan;32(1):64-6. Review.

PMID:
17305908
11.

Acetylcysteine treatment for non-acetaminophen-induced acute liver failure.

Sklar GE, Subramaniam M.

Ann Pharmacother. 2004 Mar;38(3):498-500. Epub 2004 Jan 12. Review.

PMID:
14742832
12.

[Mucolytics in acute and chronic respiratory tract disorders. I. Pathophysiology and mechanisms of action].

Kupczyk M, Kuna P.

Pol Merkur Lekarski. 2002 Mar;12(69):245-7. Review. Polish.

PMID:
12053600
13.

The role of N-acetylcysteine in the treatment of chronic obstructive pulmonary disease.

van Herwaarden CL, Bast A, Dekhuijzen PN.

Neth J Med. 1995 Aug;47(2):45-8. Review. No abstract available.

PMID:
7566280
14.

Evidence-based practice for the use of N-acetylcysteine.

Marthaler MT, Keresztes PA.

Dimens Crit Care Nurs. 2004 Nov-Dec;23(6):270-3. Review.

PMID:
15586041
15.

N-acetylcysteine in the prevention of contrast-induced nephropathy.

Fishbane S.

Clin J Am Soc Nephrol. 2008 Jan;3(1):281-7. Epub 2007 Nov 14. Review.

16.

[N-acetyl-L-cysteine as a therapeutic option in bacterial meningitis].

Klein M, Koedel U, Pfister HW.

Nervenarzt. 2007 Feb;78(2):202-5. Review. German.

PMID:
17235423
17.

From mucolytic to antioxidant and liver protection: new aspects in the intensive care unit career of N-acetylcysteine.

Kiefer P, Vogt J, Radermacher P.

Crit Care Med. 2000 Dec;28(12):3935-6. Review. No abstract available.

PMID:
11153640
18.

[Clinical application of N-acetylcysteine in liver disease].

Wu G, Guo SH.

Zhonghua Gan Zang Bing Za Zhi. 2004 Mar;12(3):185-6. Review. Chinese. No abstract available.

PMID:
15059315
19.

N-acetylcysteine use to prevent contrast medium-induced nephropathy: premature phase III trials.

Stenstrom DA, Muldoon LL, Armijo-Medina H, Watnick S, Doolittle ND, Kaufman JA, Peterson DR, Bubalo J, Neuwelt EA.

J Vasc Interv Radiol. 2008 Mar;19(3):309-18. doi: 10.1016/j.jvir.2007.11.003. Review.

PMID:
18295688
20.

Theory and practice of the use of expectorants reviewed from clinical aspects.

Nagy G.

Ther Hung. 1984;32(1):6-12. Review. No abstract available.

PMID:
6400475

Supplemental Content

Support Center